Protected magnesium alloys for bioresorbable stents

US10322214B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10322214-B2
Application numberUS-201514934645-A
CountryUS
Kind codeB2
Filing dateNov 6, 2015
Priority dateNov 6, 2014
Publication dateJun 18, 2019
Grant dateJun 18, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Biodegradable magnesium alloy implantable medical devices are protected to delay onset of corrosion, and thus biodegradability, or to corrode more uniformly. The protection allows for extended effective use of the devices while maintaining biodegradability. Examples of protective coatings include conversion coatings that at least partially remove exposed second phases from a surface of the magnesium alloy and coatings that provide a barrier between water and the surface of the magnesium alloy.

First claim

Opening claim text (preview).

The invention claimed is: 1. A biodegradable implantable medical device, comprising a magnesium (Mg) alloy; and a coating on the Mg alloy, wherein the coating comprises (i) a conversion coating that removes exposed second phases from a surface of the Mg alloy; and (ii) one or more moisture barrier layers; wherein the one or more barrier layers comprise a layer selected from the group consisting of aluminum, magnesium, cerium oxide, aluminum oxide, titanium ethylene glycol, titanium propylene glycol, zirconium oxide, zirconium ethylene glycol, zirconium propylene glycol, hafnium oxide, hafnium ethylene glycol, hafnium propylene glycol, aluminum fluoride, or magnesium fluoride. 2. The biodegradable implantable medical device of claim 1 , wherein the conversion comprises a conversion coating selected from the group consisting of: a hydrofluoric acid (HF) conversion coating; a conversion coating with acidic or basic solutions of Ce 3+ or Ce 4+ ; a conversion coating with an acidic or basic solution comprising an inorganic magnesium precipitating agent; and a conversion coating with an acidic or basic solution comprising an organic magnesium precipitating agent. 3. The biodegradable implantable medical device of claim 1 , wherein the conversion coating comprises an inorganic magnesium precipitating agent selected from the group consisting of a phosphate, a silicate, a permanganate, a hydrotalcite, a vanadate, a chromate and a Rare Earth ion other than a cerium ion. 4. The biodegradable implantable medical device of claim 1 , wherein the conversion coating comprises an organic magnesium precipitating agent selected from the group consisting of 4-(4-nitrophenylazo)-resorcinol, 8-hydroxy quinolone, and sodium dodecylbenzenesulphonate. 5. The biodegradable medical device of claim 1 , wherein the conversion coating comprises an HF conversion coating. 6. The biodegradable medical device of claim 1 , wherein the one or more moisture barrier layers comprise a layer of aluminum oxide and a layer of poly(aluminum ethylene glycol). 7. The biodegradable medical device of claim 1 , wherein the one or more moisture barrier layers comprise a layer of aluminum oxide and a layer of cerium oxide. 8. A biodegradable frame for an implantable medical stent, the frame comprising: a magnesium (Mg) alloy; and a coating on the Mg alloy, wherein the coating comprises a hydrofluoric acid (HF) conversion coating layer on the Mg alloy, and alternating layers of aluminum oxide (Al 2 O 3 ) and a poly(aluminum ethylene glycol) polymer (alucone) on the HF conversion coating layer. 9. The frame of claim 8 , wherein the coating comprises the HF conversion coating layer on the Mg alloy, a base layer of Al 2 O 3 on the HF conversion coating layer, a nanolaminate of Al 2 O 3 and alucone on the base layer of Al 2 O 3 , and a layer of alucone on the nanolaminate of Al 2 O 3 and alucone. 10. The frame of claim 9 , wherein the total thickness of the base layer of Al 2 O 3 , the nanolaminate of Al 2 O 3 and alucone, and the layer of alucone is 100 nanometers or less. 11. A biodegradable frame for an implantable medical stent, the frame comprising: a magnesium (Mg) alloy; and a coating on the Mg alloy, wherein the coating comprises a layer of aluminum oxide and a layer of cerium oxide. 12. A biodegradable frame for an implantable medical stent, the frame comprising: a magnesium (Mg) alloy; and a coating on the Mg alloy, wherein the coating comprises a layer of aluminum oxide and a layer of poly(aluminum ethylene glycol).

Assignees

Inventors

Classifications

  • characterised by the deposition of metallic material · CPC title

  • connected peak to trough · CPC title

  • Coatings comprising two or more layers · CPC title

  • Carbon; Graphite · CPC title

  • A61L31/088Primary

    Other specific inorganic materials not covered by A61L31/084 or A61L31/086 · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10322214B2 cover?
Biodegradable magnesium alloy implantable medical devices are protected to delay onset of corrosion, and thus biodegradability, or to corrode more uniformly. The protection allows for extended effective use of the devices while maintaining biodegradability. Examples of protective coatings include conversion coatings that at least partially remove exposed second phases from a surface of the magn…
Who is the assignee on this patent?
Medtronic Vascular Inc
What technology area does this patent fall under?
Primary CPC classification A61L31/088. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).